Moran Wealth Management LLC Sells 17,543 Shares of Cabot Corporation $CBT

Moran Wealth Management LLC lowered its holdings in Cabot Corporation (NYSE:CBT) by 36.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,122 shares of the specialty chemicals company’s stock after selling 17,543 shares during the period. Moran Wealth Management LLC’s holdings in Cabot were worth $2,344,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. UBS Group AG increased its holdings in Cabot by 3.5% in the 4th quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock worth $40,708,000 after purchasing an additional 20,668 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Cabot by 5.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock valued at $118,392,000 after purchasing an additional 73,734 shares in the last quarter. Denali Advisors LLC acquired a new stake in shares of Cabot during the fourth quarter valued at about $5,531,000. Victory Capital Management Inc. grew its holdings in shares of Cabot by 259.2% during the third quarter. Victory Capital Management Inc. now owns 142,404 shares of the specialty chemicals company’s stock worth $10,830,000 after purchasing an additional 102,764 shares during the last quarter. Finally, Peregrine Capital Management LLC grew its holdings in shares of Cabot by 24.7% during the fourth quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company’s stock worth $5,246,000 after purchasing an additional 15,669 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Down 0.1%

CBT stock opened at $86.29 on Monday. The stock’s 50 day simple moving average is $84.52 and its 200 day simple moving average is $76.52. The company has a market cap of $4.45 billion, a P/E ratio of 16.31, a price-to-earnings-growth ratio of 11.36 and a beta of 0.83. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period last year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts expect that Cabot Corporation will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were given a dividend of $0.4725 per share. The ex-dividend date of this dividend was Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot’s dividend payout ratio (DPR) is 35.73%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CBT. JPMorgan Chase & Co. raised their price target on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Truist Financial assumed coverage on Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 target price for the company. Finally, Mizuho lifted their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $85.80.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.